Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Aging-related Gene - Novel LIM Protein S2-6 (96-07)

University of Arkansas for Medical Sciences
Overexpressed in Werner's Syndrome Fibroblasts

Mechanism of action

Senescence of human fibroblasts

Full description

S2-6 is a novel protein coded by a complimentary DNA clone discovered by university researchers during screening of the Werner syndrome cDNA library for overexpressed genes, which are involved in senescence of human fibroblasts. The data confirm that the S2-6 cDNA codes for a novel LIM protein specific for non-proliferating cells, whose function is involved in the inhibition of DNA synthesis. The LIM protein contains zinc finger DNA binding domains reminiscent of the emerging family of LIM proteins, which have a role in the regulation of cell growth. The mRNA is exclusively expressed in non-proliferating normal cells. Injection of antisense into normal non-proliferating human fibroblast stimulates DNA synthesis, indicating that the S2-6 role is in the inhibition of DNA synthesis. This family of genes is defined by the presence of 1-3 repeats of a 52 residue segment containing two adjacent zinc binding domains separated by a 2 residue linker.

96-07

Development status

Preclinical

Patent information

Patent Status: Issued US# 5,959,081 License Status: Available for non-exclusive License

Type of business relationship sought

Additional Licensing Partner (non-exclusive) to further commercialize this patented technology

Licensing contact

Mr. Charles Cook
Licensing Associate
UAMS BioVentures - TLO
Request more information

More information

For more information about the product please visit website.

Company details

University of Arkansas for Medical Sciences
Medical School - Teaching Hospital - Research Institution

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Partnering consultation free of charge
Pharmalicensing Jobs 1
Maximizing Pharmaceutical Patent Lifecycles
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us